{"nct_id":"NCT01659086","title":"Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age","status":"COMPLETED","status_verified_date":"2018-06","start_date":"2012-08-22","start_date_type":"ACTUAL","primary_completion_date":"2012-10-26","primary_completion_date_type":"ACTUAL","completion_date":"2014-03-19","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}